Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05848297 · ClinicalTrials.gov registry record
Automated Robotic TCD in Traumatic Brain Injury
A clinical trial of Brain Injuries, Traumatic, sponsored by Virginia Commonwealth University.
- Recruiting
- Registry status
- 30
- Enrollment target
- 3
- Study locations
NCT05848297: Recruiting study of Brain Injuries, Traumatic, sponsored by Virginia Commonwealth University.
NCT05848297 is a study of Brain Injuries, Traumatic that is actively recruiting participants, run by Virginia Commonwealth University. The registered enrollment target is 30 participants, below the 255-participant average among 21 other Brain Injuries, Traumatic trials with a reported enrollment target (88% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05848297, a study of Brain Injuries, Traumatic, is actively recruiting participants, sponsored by Virginia Commonwealth University.
- RECRUITING
- Registry status
- 30 participants
- Enrollment target
- 3
- Study locations
Study Summary
This study's objective is to determine the safety, feasibility and efficacy of prolonged automated robotic TCD monitoring in critically ill patients with severe TBI across multiple clinical sites with varying levels of TCD availability and experience
Primary Outcome
To evaluate the safety of prolonged automated robotic TCD monitoring in severe TBI population. Bedside nurse will describe
Conditions Studied
Interventions
- DEVICE Transcranial Doppler ultrasonography (TCD)
Study Locations (3)
California
- University of California, Davis - Davis
North Carolina
- Wake Forest University - Winston-Salem
Virginia
- Virginia Commonwealth University - Richmond
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2025-05-20 |
| Est. Completion | 2026-05 |
What NCT05848297 shows while recruiting
NCT05848297 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 255-participant average among 21 other Brain Injuries, Traumatic trials with a reported enrollment target (88% lower).
The record links to 1 condition, with Brain Injuries, Traumatic appearing as the primary indexed condition, and to 1 intervention - of which Transcranial Doppler ultrasonography (TCD) is the first listed.
NCT05848297 reports a single indexed study location in California, North Carolina, Virginia.
Frequently Asked Questions
What is clinical trial NCT05848297 about?
NCT05848297 is a clinical study titled "Automated Robotic TCD in Traumatic Brain Injury". This study's objective is to determine the safety, feasibility and efficacy of prolonged automated robotic TCD monitoring in critically ill patients with severe TBI across multiple clinical sites with varying levels of TCD availability and experience
What is the current status of trial NCT05848297?
This trial is currently recruiting. The enrollment target is 30 participants. The study started on 2025-05-20. Estimated completion is 2026-05.
What conditions does trial NCT05848297 study?
This clinical trial studies the following conditions: Brain Injuries, Traumatic.
What interventions are being tested in trial NCT05848297?
The interventions under investigation include: Transcranial Doppler ultrasonography (TCD) (DEVICE).
Who is sponsoring clinical trial NCT05848297?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05848297 being conducted?
This trial has 3 study locations across California, North Carolina, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Brain Injuries, Traumatic
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05848297's enrollment target sits among peer trials
30 19th of 21 higher than 3 of 21 other Brain Injuries, Traumatic trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Brain Injuries, Traumatic trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Morning Bright Light to Improve Sleep Quality in Veterans
RECRUITING · NA
-
mTBI Identification and Monitoring Through Retinal Scanning
RECRUITING
-
Remotely Supervised tDCS+ for Complex Attention in mTBI (Cognetric)
RECRUITING · NA
-
Brain Oxygen Optimization in Severe TBI, Phase 3
RECRUITING · NA
-
Buspirone and Melatonin for Depression Following Traumatic Brain Injury
RECRUITING · Phase 4
-
NEUROBALANCE Training to Improve Postural Control in Individuals With Traumatic Brain Injury
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI